Disseminated cutaneous leishmaniasis: epidemiological, clinical and laboratory aspects
Contenido principal del artículo
Resumen
Disseminated leishmaniasis is a severe and emerging form of American tegumentary leishmaniasis. Disseminated leishmaniasis is defined by the presence of more than 10 polymorphic skin lesions, distributed over more than two non-contiguous parts of the body. Involvement of the nasal mucosa is observed in almost half of the cases. The development of disseminated leishmaniasis is poorly understood and is related to a complex network involving environmental, host immune response, and parasitic factors, in which L. braziliensis. Disseminated leishmaniasis is a difficult disease to cure, presenting a high failure rate of 75% to therapy with pentavalent antimony. Despite its importance and severity, this form of American tegumentary leishmaniasis has been poorly studied and documented, so it deserves more attention from professionals working in endemic areas.
Detalles del artículo
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Esta revista proporciona acceso gratuito a su contenido a través de su sitio web siguiendo el principio de que hacer que la investigación esté disponible de forma gratuita para el público apoya un mayor intercambio de conocimiento global. El contenido web de la revista se distribuye bajo un Attribution-NonCommercial-ShareAlike 4.0 International.
Citas
Hashiguchi, Y., Gómez, EL, Kato, H. et al. Leishmaniasis cutánea difusa y diseminada: casos clínicos vividos en el Ecuador y una breve revisión. Trop Med Health 44, 2 (2016). https://doi.org/10.1186/s41182-016-0002-0.
Machado GU, Prates FV, Machado PRL. Disseminated leishmaniasis: clinical, pathogenic, and therapeutic aspects. An Bras Dermatol. 2019 Jan-Feb;94(1):9-16. doi: 10.1590/abd1806-4841.20198775.
Vélez I, D, Jiménez A, Vásquez D, Robledo S, M: Disseminated Cutaneous Leishmaniasis in Colombia: Report of 27 Cases. Case Rep Dermatol 2015;7:275-286. doi: 10.1159/000441120.
Paniz Mondolfi AE, Duffey GB, Horton LE, Tirado M, Reyes Jaimes O, Perez-Alvarez A, Zerpa O. Intermediate/borderline disseminated cutaneous leishmaniasis. Int J Dermatol. 2013 Apr;52(4):446-55. doi: 10.1111/j.1365-4632.2012.05709.x.
de Vries HJC, Schallig HD. Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management Developments. Am J Clin Dermatol. 2022 Nov;23(6):823-840. doi: 10.1007/s40257-022-00726-8.
de Vries HJ, Reedijk SH, Schallig HD. Cutaneous leishmaniasis: recent developments in diagnosis and management. Am J Clin Dermatol. 2015 Apr;16(2):99-109. doi: 10.1007/s40257-015-0114-z.
Mancheno-Valencia A, Cabezas-Arteaga J, Sacoto-Aizaga K, Arenas-Guzmáno R. Caso clínico: leishmaniasis cutánea diseminada (LCD) [Case report: disseminated cutaneous leishmaniasis (LCD)]. Gac Med Mex. 2017 Mar-Apr;153(2):251-254.
McGwire BS, Satoskar AR. Leishmaniasis: clinical syndromes and treatment. QJM. 2014 Jan;107(1):7-14. doi: 10.1093/qjmed/hct116.
Elmahallawy EK, Sampedro Martinez A, Rodriguez-Granger J, Hoyos-Mallecot Y, Agil A, Navarro Mari JM, Gutierrez Fernandez J. Diagnosis of leishmaniasis. J Infect Dev Ctries. 2014 Aug 13;8(8):961-72. doi: 10.3855/jidc.4310.
Georgiadou SP, Makaritsis KP, Dalekos GN. Leishmaniasis revisited: Aspectos actuales sobre epidemiología, diagnóstico y tratamiento. J Transl Int Med. 2015 abril-junio;3(2):43-50. doi: 10.1515/jtim-2015-0002. Epub 30 de junio de 2015.